Neuroblastoma: Difference between revisions
Jump to navigation
Jump to search
Mahshid |
No edit summary |
||
Line 3: | Line 3: | ||
'''For patient information click [[{{PAGENAME}} (patient information)|here]]'''. | '''For patient information click [[{{PAGENAME}} (patient information)|here]]'''. | ||
{{CMG}} {{AE}}{{HL}} | {{CMG}} {{AE}}{{ZAS}}{{HL}} | ||
{{SK}} Neuroblastomas; Sympathicoblastoma; Sympathicoblastomas; NB; Neuroblastoma sympathicum | {{SK}} Neuroblastomas; Sympathicoblastoma; Sympathicoblastomas; NB; Neuroblastoma sympathicum |
Latest revision as of 17:29, 28 February 2019
Neuroblastoma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Neuroblastoma On the Web |
American Roentgen Ray Society Images of Neuroblastoma |
For patient information click here.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Zahir Ali Shaikh, MD[2]Haytham Allaham, M.D. [3]
Synonyms and keywords: Neuroblastomas; Sympathicoblastoma; Sympathicoblastomas; NB; Neuroblastoma sympathicum
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Neuroblastoma from other diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Staging | History and Symptoms | Physical Examination | Laboratory tests | X Ray | CT | MRI | Echocardiography or Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical therapy | Surgery | Cost-Effectiveness of Therapy | Future or Investigational Therapies
Additional Reading
- Neuroblastoma: biological insights into a clinical enigma. Brodeur GM. Nature Reviews Cancer. 2003 Mar;3(3):203-16. PMID 12612655
- Current aspects of biology, risk assessment, and treatment of neuroblastoma. Haase GM, Perez C, Atkinson JB. Semin Surg Oncol. 1999 Mar;16(2):91-104. PMID 9988866